Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash & Current Investments (2022 - 2025)

Maravai Lifesciences Holdings has reported Cash & Current Investments over the past 4 years, most recently at $216.9 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $216.9 million for Q4 2025, down 33.01% from a year ago — trailing twelve months through Dec 2025 was $216.9 million (down 33.01% YoY), and the annual figure for FY2025 was $216.9 million, down 33.01%.
  • Cash & Current Investments for Q4 2025 was $216.9 million at Maravai Lifesciences Holdings, down from $243.6 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for MRVI hit a ceiling of $632.1 million in Q4 2022 and a floor of $216.9 million in Q4 2025.
  • Median Cash & Current Investments over the past 4 years was $568.3 million (2023), compared with a mean of $452.1 million.
  • Biggest five-year swings in Cash & Current Investments: dropped 0.07% in 2024 and later tumbled 57.87% in 2025.
  • Maravai Lifesciences Holdings' Cash & Current Investments stood at $632.1 million in 2022, then dropped by 9.04% to $575.0 million in 2023, then crashed by 43.69% to $323.8 million in 2024, then crashed by 33.01% to $216.9 million in 2025.
  • The last three reported values for Cash & Current Investments were $216.9 million (Q4 2025), $243.6 million (Q3 2025), and $269.9 million (Q2 2025) per Business Quant data.